CIDRAP-ASP Newsletter - June 2025

Antimicrobial Stewardship Project Newsletter

In this Issue

  • New from CIDRAP-ASP: Antimicrobial resistance (AMR) journalism and our June quiz
     
  • Global news and reports on the value of AMR diagnostics and the economic consequences of AMR
     
  • Regional AMR news and projects from the African region, Australia, Ireland, Uganda, the United Kingdom, and the United States

New at CIDRAP-ASP

Two seated adults receive intravenous chemotherapy

AMR and Cancer

Test your knowledge about the risks associated with drug-resistant infections in people who have cancer and receive care in outpatient settings.

Global AMR News and Tools

Two lab technicians, one holding a pipette and one looking into a microscope

Value of AMR diagnostics. In a report for the Office of Health Economics and commissioned by bioMérieux, Henry Fong, MPharm, MSc, George Bray, MSc, Grace Hampson, MSc, and Lotte Steuten, PhD, MSc, assess the value of AMR diagnostics at the individual, population, and health-system levels within the context of reimbursement and policy frameworks. Learn more.
 

Economic consequences of AMR. In a working paper for the Peterson Institute for International Economics, Roshen Fernando, PhD, MSc, MBA, and Warwick J. McKibbin, PhD, MA, model global economic consequences of AMR—particularly those that intersect with climate change, demographic changes, and environmental pollution—under six scenarios. Learn more.

Regional AMR Case Studies

Several capsules on a paper map of Africa

African region. On the PLoS Speaking of Medicine blog, Sherin Paul, MBBS, MD, MSc, and Mirfin Mpundu, DrPH, MPH, MBA, describe innovative AMR financing strategies that may help African countries reduce their dependence on external funding and priorities. Learn more. 
 

African region. In a commentary for Harvard Law School's Petrie-Flom Center, Ibrahim Kamara, MBChB, MSc-IPH, describes the need for Africa to lead efforts against AMR and develop robust hospital-based antimicrobial stewardship programs that are inclusive of infection prevention and control best practices and ongoing evaluation. Learn more.
 

African region. Karolinska Institutet announced the launch of the UTI-Diag project, which aims to improve the detection and treatment of urinary tract infections (UTIs), reduce AMR and inappropriate antibiotic use, and enhance access to novel diagnostic tools, particularly across-sub-Saharan Africa and among pregnant people and children. Learn more.
 

Australia. CSIRO and The Lens published the AMR Lens Report on research and innovation in Australia, noting an increasing number of AMR-related publications in Australia over the past 40 years, along with the need for more innovation in antifungal, antiparasitic, and antiviral agents. Learn more.
 

Ireland. A report led by Maynooth University and launched by Ireland's Department of Agriculture, Food and the Marine and Department of Health provides recommendations for the future of AMR research in the country. Learn more.
 

Uganda. In a One Health Trust policy report, Oluoma Agiri, DVM, MSc, Erta Kalanxhi, PhD, MSc, Simran More, MSc, Felix Bahati, MSc, Rishiraj Bhagawati, MA, and Samantha Serrano, ScD, describe the role of vaccines and provide recommendations for strengthening national immunization programs as a means of addressing AMR in Uganda. Learn more.
 

United Kingdom. In a brief video for the British Society for Antimicrobial Chemotherapy, Gavin Barlow, MBChB, MD, discusses recruitment for the BioDriveAFS Trial, which aims to prevent and manage invasive fungal disease in patients with acute leukemia who are receiving intensive chemotherapy across 16 UK sites. Learn more.
 

United Kingdom. The British Association for Sexual Health and HIV published national clinical guidelines on the use of doxycycline post-exposure prophylaxis (doxyPEP) for the prevention of syphilis in the UK. Learn more.
 

United States. The US Centers for Disease Control and Prevention National Healthcare Safety Network published a report on antibiotic use during 2023 reported by 2,426 hospitals using the Standardized Antimicrobial Administration Ratio. Broad-spectrum antibiotic use for community-acquired infections increased in pediatric intensive care units and wards in 2023 compared with 2022, which the authors say may have been driven by a surge of respiratory illness and the national amoxicillin shortage. Learn more.

Facebook
LinkedIn
Twitter
RSS Feeds

Center for Infectious Disease Research and Policy
Research and Innovation Office, University of Minnesota, Minneapolis, MN

Copyright © 2026 Regents of the University of MN
Research and Innovation Office, University of MN

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.